About Xenon Pharmaceuticals
Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of proprietary and partnered neurology therapies to address areas, with a focus on epilepsy. Two candidates in this pipeline aim to address rare, severe, pediatric forms of epilepsy: KCNQ2-DEE and SCN8A-DEE. Xenon will post on its social media channels on Feb. 28th to raise awareness for Rare Disease Day.